Literature DB >> 9822268

Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation.

J R Brown1, J Kleimberg, M Marini, G Sun, A Bellini, S Mattoli.   

Abstract

We investigated the kinetics of allergen-induced eotaxin expression and its relationship to eosinophil accumulation and activation in the airways of patients with allergic asthma. Twenty-four patients with allergic asthma and late asthmatic responses to allergen inhalation were randomly allocated into three groups of eight patients each, who received bronchoscopy with bronchial biopsies and BAL at 2, 4 and 24 h, respectively, after the inhalation of the diluent and the allergen. The expression of eotaxin mRNA and protein and eotaxin release were evaluated by in situ hybridization, immunohistochemistry, immunocytochemistry, and radioimmunoassay. Increased transcription from the eotaxin gene preceded the appearance of the late asthmatic response and the influx of activated eosinophils in bronchial tissue and BAL fluid (BALF). This was followed by increased cell expression of eotaxin protein (P<0.001) and increased eotaxin release (P<0.001), which correlated with the numbers of total and activated eosinophils and the level of airflow obstruction at 4 h after allergen exposure (P<0.05 for all correlations). At 24 h after allergen inhalation, enhanced eotaxin expression declined without a similar reduction in the numbers of eosinophils in bronchial biopsies and when there was a further increase in the number of these cells in BALF (P<0.05). These results indicate that eotaxin contributes to the early phase of allergen-induced recruitment of activated eosinophils into the airways of patients with allergic asthma and that other factors are implicated in the persistence of eosinophil infiltration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822268      PMCID: PMC1905105          DOI: 10.1046/j.1365-2249.1998.00688.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  A bronchial epithelial cell-derived factor in asthma that promotes eosinophil activation and survival as GM-CSF.

Authors:  M Soloperto; V L Mattoso; A Fasoli; S Mattoli
Journal:  Am J Physiol       Date:  1991-06

2.  Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  1991-09       Impact factor: 10.793

3.  Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  1991-11       Impact factor: 10.793

4.  Specific binding of endothelin on human bronchial smooth muscle cells in culture and secretion of endothelin-like material from bronchial epithelial cells.

Authors:  S Mattoli; M Mezzetti; G Riva; L Allegra; A Fasoli
Journal:  Am J Respir Cell Mol Biol       Date:  1990-08       Impact factor: 6.914

Review 5.  Late asthmatic responses.

Authors:  P M O'Byrne; J Dolovich; F E Hargreave
Journal:  Am Rev Respir Dis       Date:  1987-09

6.  Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein.

Authors:  P C Tai; C J Spry; C Peterson; P Venge; I Olsson
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

7.  Eosinophilic inflammation in asthma.

Authors:  J Bousquet; P Chanez; J Y Lacoste; G Barnéon; N Ghavanian; I Enander; P Venge; S Ahlstedt; J Simony-Lafontaine; P Godard
Journal:  N Engl J Med       Date:  1990-10-11       Impact factor: 91.245

8.  Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma.

Authors:  S Mattoli; V L Mattoso; M Soloperto; L Allegra; A Fasoli
Journal:  J Allergy Clin Immunol       Date:  1991-04       Impact factor: 10.793

9.  Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions.

Authors:  J G De Monchy; H F Kauffman; P Venge; G H Koëter; H M Jansen; H J Sluiter; K De Vries
Journal:  Am Rev Respir Dis       Date:  1985-03

10.  Recombinant human interleukin 5 is a selective activator of human eosinophil function.

Authors:  A F Lopez; C J Sanderson; J R Gamble; H D Campbell; I G Young; M A Vadas
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  29 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Chemokines in allergic lung inflammation.

Authors:  Clare Lloyd
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

3.  Eosinophilic venulitis in the small intestines in a mouse model of late asthma.

Authors:  Linh Kan Bui; Toshiharu Hayashi; Tomomi Nakashima; Yoichiro Horii
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

Review 4.  Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies.

Authors:  Manuel A R Ferreira
Journal:  Mediators Inflamm       Date:  2003-10       Impact factor: 4.711

5.  Functional characterization and biomarker identification in the Brown Norway model of allergic airway inflammation.

Authors:  Stephen L Underwood; El-Bdaoui Haddad; Mark A Birrell; Kerryn McCluskie; Michaela Pecoraro; Dominika Dabrowski; Stephen E Webber; Martyn L Foster; Maria G Belvisi
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

6.  Eotaxin expression in Sephadex-induced lung injury in rats.

Authors:  R F Guo; P A Ward; J A Jordan; M Huber-Lang; R L Warner; M M Shi
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

7.  A hexanucleotide repeat upstream of eotaxin gene promoter is associated with asthma, serum total IgE and plasma eotaxin levels.

Authors:  Jyotsna Batra; Reenu Rajpoot; Jasmine Ahluwalia; Satish K Devarapu; Surendra K Sharma; Amit K Dinda; Balaram Ghosh
Journal:  J Med Genet       Date:  2007-01-12       Impact factor: 6.318

8.  Blocking cyclophilins in the chronic phase of asthma reduces the persistence of leukocytes and disease reactivation.

Authors:  Erik J Stemmy; Molly A Balsley; Rosalyn A Jurjus; Jesse M Damsker; Michael I Bukrinsky; Stephanie L Constant
Journal:  Am J Respir Cell Mol Biol       Date:  2011-04-14       Impact factor: 6.914

9.  Genetic interactions model among Eotaxin gene polymorphisms in asthma.

Authors:  June-Hyuk Lee; Jason H Moore; Sung-Woo Park; An-Soo Jang; Soo-Taek Uh; Yong Hoon Kim; Choon-Sik Park; Byung Lae Park; Hyoung Doo Shin
Journal:  J Hum Genet       Date:  2008-08-20       Impact factor: 3.172

Review 10.  Chemokines and their receptors in the allergic airway inflammatory process.

Authors:  Juan Raymundo Velazquez; Luis Manuel Teran
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.